{
    "nct_id": "NCT03831100",
    "official_title": "A Single-Site, Parallel-Group, Randomized-Controlled Pilot Trial Comparing BRIGHT With Active Control in Reducing Body Image Disturbance Among Head and Neck Cancer Survivors (BRIGHT 2.0)",
    "inclusion_criteria": "Healthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Inability to speak or write English\n2. Pre-existing, ongoing CBT services for other disorders and the participant is not willing to discontinue the prior therapy for the duration of the proposed trial.\n3. Initiation or adjustment (< 3 months of baseline) of psychotropic medication.\n4. Severe psychiatric comorbidity (e.g. suicidal ideation, psychosis)",
    "miscellaneous_criteria": "Inclusion Criteria\n\n1. Age > 18 years at the time of screening\n2. History of pathologically confirmed invasive squamous cell carcinoma (or histologic variant) of the upper aerodigestive tract (oral cavity, pharynx, larynx, nose/paranasal sinuses), carcinoma of a major or minor salivary gland, or cutaneous malignancy of the face or neck\n3. History of curative intent surgery with or without adjuvant therapy, with or without reconstruction\n4. American Joint Committee on Cancer (AJCC) 8th Edition pathologic stage grouping I-IV\n5. Completion of oncologic treatment within 12 months of study enrollment (but no sooner than 6 weeks post-treatment completion)\n6. No planned significant HNC ablative or reconstructive surgery (defined by a postoperative inpatient stay of at least three days) during the study intervention or follow-up period as determined by the HNC oncologic surgeon at the time of study accrual\n7. Willingness to be randomized to either BRIGHT or AC\n8. Body Image Scale (BIS) score >/= 10"
}